News ResMed, Inc.

Equities

RMD

US7611521078

Real-time Estimate Cboe BZX Other stock markets 11:43:12 2024-04-26 am EDT			5-day change	1st Jan Change
211.7 ^USD	+15.42%		+20.97%	+25.77%

05:37pm	KeyBanc Adjusts Price Target on ResMed to $238 From $227	MT
05:04pm	ResMed's Fiscal Q3 Non-GAAP Earnings, Revenue Increase; Shares Up Over 17%	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

KeyBanc Adjusts Price Target on ResMed to $238 From $227	11:37am	MT
ResMed's Fiscal Q3 Non-GAAP Earnings, Revenue Increase; Shares Up Over 17%	11:04am	MT
Jefferies Adjusts Price Target on ResMed to $180 From $164	10:36am	MT
Oppenheimer Adjusts ResMed Price Target to $200 From $205, Maintains Outperform Rating	09:09am	MT
JPMorgan Adjusts Price Target on ResMed to $225 From $198	09:00am	MT
Mizuho Adjusts Price Target on ResMed to $220 From $215	08:09am	MT
Needham Adjusts Price Target on ResMed to $236 From $224	08:01am	MT
Morgan Stanley Adjusts Price Target on ResMed to $219 From $207	06:40am	MT
RBC Adjusts Price Target on ResMed to $200 From $187	06:18am	MT
ResMed Declares Quarterly Dividend as Fiscal Q3 Profit Jumps 29%; Shares Up 7%	11:21pm	MT
ResMed tops quarterly profit estimates on strong demand for sleep apnea devices	06:12pm	RE
ResMed : Q3 2024 ResMed Earnings Results Webcast Corporate 1-Pager	06:02pm	PU
ResMed : Q3 2024 ResMed Earnings Results Webcast Presentation	06:02pm	PU
ResMed Fiscal Q3 Non-GAAP Earnings, Revenue Increase; Shares Rise After Hours	Apr. 25	MT
Transcript : ResMed Inc., Q3 2024 Earnings Call, Apr 25, 2024	Apr. 25
ResMed: Fiscal Q3 Earnings Snapshot	Apr. 25	AQ
ResMed Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	Apr. 25	CI
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024	Apr. 25	GL
ResMed Inc. Declares Quarterly Cash Dividend, Payable on June 13, 2024	Apr. 25	CI
Wall St set for higher open on megacaps boost; earnings, Fed comments on tap	Apr. 17	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ResMed, Inc. continues to make headway in the sleep market

December 11, 2023 at 05:55 am EST